Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.9M Buy
147,600
+120,800
+451% +$13.8M ﹤0.01% 1336
2026
Q2
$3.17M Sell
26,800
-8,000
-23% -$923K ﹤0.01% 2590
2026
Q1
$4.16M Buy
+34,800
New +$4.56M ﹤0.01% 1945
2025
Q4
– Sell
-12,100
Closed -$1.78M – 4497
2025
Q3
$1.78M Buy
+12,100
New +$1.68M ﹤0.01% 2310

Other funds holding XYL

IMC Chicago's XYL Position: Q3 2026 in Review

IMC Chicago increased its Xylem (XYL) stake by 71% in Q3 2026, buying an estimated $2.34M and bringing the position to 49,401 shares worth $5M. The position accounts for ﹤0.01% of the portfolio, ranked #2228.

IMC Chicago first reported a position in XYL in Q1 2026 and has held it in 3 quarters since. 537 funds tracked by Wall St. Rank hold XYL as of Q3 2026.

  • IMC Chicago held 49,401 shares of Xylem worth $5M as of Q3 2026.
  • IMC Chicago bought 20,489 Xylem shares in Q3 2026, an estimated $2.34M.
  • Xylem made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #2228 holding.
  • IMC Chicago first reported a position in Xylem in Q1 2026 and has held it in 3 quarters since.
  • 537 funds tracked by Wall St. Rank held Xylem as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.